Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRU-guided antiplatelet therapy in diabetic PAD
NCT02762864Unknown
- Sponsor
- Chang Gung Memorial Hospital
- Start
- May 2016
- Primary completion
- Apr 2019
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of ticagrelor in peripheral artery disease (PAD), sponsored by Chang Gung Memorial Hospital. Primary endpoint: Peak exercise time at 12 months. Status: unknown.
02
Drugs
ticagrelor
03
Conditions
peripheral artery disease (PAD)
Beyond the preview
Go deeper on NCT02762864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02762864.